Benign and Malignant Floor-of-Mouth Masses: Evaluation and Management
Floor-of-mouth masses require systematic evaluation with imaging (CT or MRI with contrast) and fine-needle aspiration (FNA) for diagnosis, as clinical examination alone is insufficient to distinguish benign from malignant lesions, and most adult neck/oral masses are neoplastic rather than infectious.
Malignant Conditions
Squamous Cell Carcinoma (Most Common Malignancy)
- Represents 33.5% of all floor-of-mouth lesions in large pathology series 1
- Risk factors include tobacco use, alcohol consumption (synergistic effect), age >40 years, and HPV infection (though HPV-positive disease outside oropharynx is rare at <6%) 2
- Five-year survival for oral cavity SCC is 49% 2
Other Malignancies
- Low-grade fibromyxoid sarcoma: Deceptively bland-appearing spindle cell tumor with malignant potential; requires molecular confirmation (FUS::CREB3L2 fusion) and aggressive local control with long-term surveillance due to late recurrence risk 3
- Metastatic disease from cutaneous malignancies or other head/neck primaries 4
Benign Conditions
Most Common Benign Lesions
- Ranula (18% of floor-of-mouth lesions): Mucus retention cyst from sublingual gland obstruction 1
- Oral leukoplakia (11.8%): White patches requiring biopsy to exclude dysplasia/malignancy 1
- Inflammatory fibrous hyperplasia (5.9%) 1
- Dermoid cysts, epidermoid cysts, thyroglossal duct cysts 5
- Venolymphatic malformations 5
- Sublingual lipoma: Rare but important differential; can mimic epidermoid cyst on imaging 6
Pediatric-Specific Considerations
In infants presenting ≤16 months with congenital floor-of-mouth masses, surgical excision is preferred over marsupialization (recurrence rate: 8.8% vs 80%) regardless of suspected diagnosis 7
Evaluation Algorithm
Step 1: Identify High-Risk Features
Do NOT prescribe antibiotics unless clear bacterial infection signs present (warmth, erythema, fever) 4. Most adult masses are neoplastic, not infectious.
High-Risk Characteristics Requiring Aggressive Workup:
- History: Mass present ≥2 weeks without fluctuation, age >40 years, tobacco/alcohol use, dysphagia, pharyngitis, voice change, unexplained weight loss, prior head/neck malignancy 4
- Physical exam: Firm consistency, fixation to adjacent tissues, size >1.5 cm, ulceration of overlying skin, nontender mass, tonsil asymmetry, oral cavity ulcers 4
Step 2: Targeted Physical Examination
Visualize the larynx, base of tongue, and pharynx mucosa using flexible fiberoptic endoscopy 4. Examine for:
- Mucosal ulceration or masses
- Tongue mobility restriction
- Tonsil asymmetry
- Skin lesions on face/neck/scalp
Step 3: Imaging
Order contrast-enhanced CT or MRI of the neck (strong recommendation) 4
- CT and MRI have similar diagnostic value for neck evaluation 2
- Critical caveat: Imaging correctly predicts final pathologic diagnosis only 59% of the time in floor-of-mouth masses 7
- Chest CT required for high-risk tumors (presence of neck adenopathies) or heavy smokers to detect distant metastases or second primary 2
- FDG-PET/CT has higher sensitivity than chest CT alone for detecting distant disease 2
Step 4: Tissue Diagnosis
Perform FNA instead of open biopsy when diagnosis remains uncertain after imaging (strong recommendation) 4
- For cystic masses on FNA or imaging: Continue evaluation until diagnosis obtained; do NOT assume benign 4
- Needle aspiration offers limited diagnostic value and should only be used for acute symptomatic management 7
Step 5: If Diagnosis Still Uncertain
Examination under anesthesia of upper aerodigestive tract BEFORE open biopsy 4
- Allows direct visualization and biopsy of primary mucosal sites
- Essential for identifying occult primary malignancies
Management Approach
For Malignant Lesions:
- Pathological confirmation mandatory 2
- Stomatological evaluation with tooth extraction if radiotherapy planned 2
- Treatment based on TNM staging: surgery, radiotherapy, or chemoradiotherapy 2
- FDG-PET recommended 10-12 weeks post-treatment to evaluate neck response 2
For Benign Lesions:
- Surgical excision is definitive treatment for most benign floor-of-mouth masses 7
- Marsupialization has unacceptably high recurrence rates (80%) and should be avoided 7
Critical Pitfalls to Avoid
- Never assume a cystic mass is benign without complete evaluation—cystic metastases occur 4
- Do not rely on imaging alone for diagnosis—59% accuracy rate means tissue diagnosis is essential 7
- Avoid empiric antibiotics in absence of infection signs—delays malignancy diagnosis 4
- Do not perform open biopsy before examination under anesthesia in high-risk patients—may miss primary site 4
- Recognize that benign-appearing histology (e.g., low-grade fibromyxoid sarcoma) can have malignant behavior—molecular testing may be required 3